NCT06698562

Brief Summary

Dental anxiety in children can prevent planned treatment from being carried out, negatively affect the child's relationship with the dentist and make the treatment process difficult. The most common sources of directly anticipated anxiety are known to be associated with pain. Painful experiences are anxiety-provoking for people of all ages, especially children.This study aims to evaluate the effect of virtual reality glassess (VR) and low-level laser therapy (LLLT) on dental anxiety and pain perception during local anaesthesia administration in paediatric patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 3, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 25, 2023

Completed
20 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2023

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

November 15, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 21, 2024

Completed
Last Updated

November 21, 2024

Status Verified

November 1, 2024

Enrollment Period

4 months

First QC Date

November 15, 2024

Last Update Submit

November 18, 2024

Conditions

Keywords

pain perceptiondental anxietychildrenvirtual realitydental laser

Outcome Measures

Primary Outcomes (3)

  • Pain perception

    In this study, each patient received both topical anaesthesia and DSLT treatment using a split-mouth design.Pain perception was measured by Wong and Baker scale. In this scale there are 6 different facial expressions ranging from very happy to very unhappy to express the level of pain.The scale includes six faces, each illustrating a different level of pain intensity: 0 (No Pain), 1 (Very Mild Pain), 2 (Mild Pain), 3 (Moderate Pain), 4 (Severe Pain) 5 (Very Very Severe Pain). The Wong Baker facial expression pain scale was evaluated right before and immediately after the application of local anesthesia by an observer physician other than the physician administering local anesthesia. The pictures on this scale were introduced to the patient in an appropriate language. Right before and immediately after local anesthetic injection, the picture chosen by the patient was recorded on the scale.

    Right before and immediately after treatment

  • Dental Anxiety

    Dental anxiety levels of the children were physiologically evaluated using the 'Venham Picture Test'. The picture chosen by the patient was recorded on the scale. The Venham Picture Test was assessed right before and immediately after local anaesthetic injection by an observer clinician other than the clinician administering the local anesthesia. The children were shown 8 pairs of pictures of boys (one "anxious" picture and one "non-anxious" picture), each drawn in a contrasting mood, and were asked to choose the picture on each card that corresponded to their feelings. A score of 1 was given if the child chose the "anxious" picture and 0 if the child chose the "non-anxious" picture. To determine the total score, the number of "anxious" pictures was summed (lowest score 0, highest score 8).

    Right before and immediately after treatment

  • Pain perception

    The "Face, Legs, Activity, Cry, Consolability (FLACC)" pain assessment scale was also evaluated during local anesthesia application by an observer clinician other than the clinician to whom local anesthesia would be applied. The patient's reactions were evaluated by observation by the researcher. Pain values were determined between 0-2 for each parameter and 0-10 for the total scale score. According to the scale, the total score was evaluated as follows: 0: No pain, 1-3: Mild pain, 4-6: Moderate pain and discomfort, 7-10: Severe pain and discomfort.

    During local anesthesia application

Secondary Outcomes (1)

  • Dental Anxiety

    Right before, during and immediately after the application of local anesthesia

Study Arms (4)

Group IIa Tell- Show-Do

ACTIVE COMPARATOR

Placebo topical anesthesia + LLLT + Local anesthesia

Other: Tell Show Do Group + LLLTOther: Tell Show Do Group

Group IIb Tell- Show-Do

PLACEBO COMPARATOR

Topical anesthesia + placebo LLLT + Local anesthesia

Other: Tell Show Do Group

Group Ia Distraction (VR)

ACTIVE COMPARATOR

Placebo topical anesthesia + LLLT + Local anesthesia

Other: Distraction with Virtual reality glassess + LLLT

Grup Ib Distraction (VR)

PLACEBO COMPARATOR

Topical anesthesia + placebo LLLT + Local anesthesia

Other: Distraction with Virtual reality glassess

Interventions

the injection site was dried with a cotton pellet and placebo topical anaesthesia was applied with a pre-sterilised wooden ear stick in a circular motion followed by laser biostimulation. The Wiser diode laser (Doctor Smile, Vicenza, Italy), a diode laser device with a wavelength of 980 nm and equipped with a 600 μm diameter fibre, was used to deliver low-level laser therapy to the area of interest. The tip of the laser carrier system was placed at a distance of 1 cm from the target tissue without contact and applied with continuous circular movements as recommended by the manufacturer. A silicone piece was placed on the end of the carrier system to ensure that the distance to the tissue remained constant in each application. The focal spot area was determined as 0.087 cm2. The power of the laser used in our study was determined as 0.3 W and the application time was selected as 60 seconds. The patient and the physician wore protective goggles during the whole procedure to prevent possi

Grup Ib Distraction (VR)

The injection area was dried with a cotton pellet before injection. A topical anaesthetic gel containing 20% benzocaine (Vision pat gel) was applied to the mucosal tissues to be injected using a pre-sterilised ear stick. After the application of the topical anaesthetic agent, the laser device was positioned in the same way, but without applying energy, and the sound of the laser device was pre-recorded and the study was blinded. In this way, a placebo effect was created and the patient was prevented from distinguishing between the laser and non-laser session. After this procedure, local anaesthesia was applied.

Group Ia Distraction (VR)

The injection site was dried with a cotton pellet and placebo topical anaesthesia was applied with a pre-sterilised wooden ear stick in a circular motion followed by laser biostimulation. The Wiser diode laser (Doctor Smile, Vicenza, Italy), a diode laser device with a wavelength of 980 nm and equipped with a 600 μm diameter fibre, was used to deliver low-level laser therapy to the area of interest. The tip of the laser carrier system was placed at a distance of 1 cm from the target tissue without contact and applied with continuous circular movements as recommended by the manufacturer. A silicone piece was placed on the end of the carrier system to ensure that the distance to the tissue remained constant in each application. The focal spot area was determined as 0.087 cm2. The power of the laser used in our study was determined as 0.3 W and the application time was selected as 60 seconds. During the whole procedure, the patient wore virtual glasses and the physician wore protective go

Group IIa Tell- Show-Do

In this session, the injection area was dried with a cotton pellet before injection. A topical anaesthetic gel containing 20% benzocaine (Vision pat gel) was applied to the mucosal tissues to be injected using a pre-sterilised ear stick. After the application of the topical anaesthetic agent, the laser device was positioned in the same way, but without applying energy, and the sound of the laser device was pre-recorded and the study was blinded. In this way, a placebo effect was created and the patient was prevented from distinguishing between the laser and non-laser session. After this procedure, local anaesthesia was applied.

Also known as: Group IIb
Group IIa Tell- Show-DoGroup IIb Tell- Show-Do

Eligibility Criteria

Age6 Years - 10 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • No history of systemic disease or infectious disease
  • Compliant with the dental treatments to be performed in the Children's Dental Hospital and able to answer the questions asked
  • Exhibiting 'positive' and 'absolutely positive' behaviours during the examination, compliant according to the Frankl scale,
  • Children with no previous experience of dental treatment with local anaesthesia

You may not qualify if:

  • Children with any systemic condition
  • Mentally and physically disabled, unable to co-operate,
  • Children allergic to local anaesthesia,
  • Previous dental treatment experience with local anaesthesia
  • Exhibiting "negative" and "strongly negative" behaviour according to the Frankl scale
  • Children with eye diseases such as myopia and astigmatism

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Altinbas University Faculty of Dentistry

Istanbul, Marmara, 34147, Turkey (Türkiye)

Location

MeSH Terms

Interventions

Low-Level Light Therapy

Intervention Hierarchy (Ancestors)

Laser TherapyTherapeuticsPhototherapy

Study Officials

  • SIRIN GUNER ONUR, PhD

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The study included 40 Frankl "positive" and "definitely positive" pediatric patients between the ages of 6 and 10, applied to Altinbaş University Faculty of Dentistry Pediatric Dentistry Clinic for routine dental treatments between January 2023 and April 2023, and had no previous local anesthesia experience. This study designed as a randomized, single-center, split-mouth, double blind clinical trial.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

November 15, 2024

First Posted

November 21, 2024

Study Start

January 3, 2023

Primary Completion

April 25, 2023

Study Completion

May 15, 2023

Last Updated

November 21, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations